fbpx

Certottica and Carl Zeiss Vision Unite Against Fogging

The laboratories of the Italian certification body Certottica and Carl Zeiss Vision have joined forces to develop a new, anti-fog coating.

The Permanent Antifog Performance project aims to develop a coating for ophthalmic and sun lenses, shields and masks leveraging cold plasma technology.

Using the new technology is potentially beneficial for the environment because it uses few raw materials without producing effluents, liquids or gases. However, the complicated nature of needing to adapt to different types of lenses increases the research project’s costs and challenges. The collaboration between the two companies aims to share costs and achieve viability.

Featured Posts

Optik VOILA January-February 2026 Marchon LO2187_714

Modern Elegance in a Sleek Teardrop Silhouette

Longchamp’s LO2187 reinterprets the Roseau concept with a lightweight metal teardrop silhouette, bamboo-inspired bridge detailing, and refined comfort for everyday wear.

Learn More
CRO logo image for Research Updates in Optik magazine

Landmark Myopia Control Trial Receives Top Recognition

A landmark six-year clinical trial on dual-focus contact lenses confirms long-term effectiveness in slowing childhood myopia progression.

Read more
Next Gen OD Future Focus event Cross-border Guidance 2026

Future Focus Webinar Addresses Cross-Border Pathways for Canadian Optometry Students

The Future Focus Cross-Border webinar provided Canadian optometry students with guidance on immigration, licensing and returning to practice in Canada.

Read more
Seneca Polytechnic logo

Seneca College Trade Show: Still Going Strong

The Seneca College Trade Show continues to connect opticianry students with key suppliers, associations and professionals across the optical industry.

Read more
The Vision Council logo

Vision Council Report: Eyecare Providers See Revenue Gains Despite Economic Pressures

The Vision Council’s Provider inSights report finds eyecare providers saw revenue gains and improved patient retention in late 2025 despite ongoing economic pressures.

Read more
Optik VOILA January-February 2026 Marchon LO2187_714

Modern Elegance in a Sleek Teardrop Silhouette

Longchamp’s LO2187 reinterprets the Roseau concept with a lightweight metal teardrop silhouette, bamboo-inspired bridge detailing, and refined comfort for everyday wear.

Learn More
CRO logo image for Research Updates in Optik magazine

Landmark Myopia Control Trial Receives Top Recognition

A landmark six-year clinical trial on dual-focus contact lenses confirms long-term effectiveness in slowing childhood myopia progression.

Read More
Next Gen OD Future Focus event Cross-border Guidance 2026

Future Focus Webinar Addresses Cross-Border Pathways for Canadian Optometry Students

The Future Focus Cross-Border webinar provided Canadian optometry students with guidance on immigration, licensing and returning to practice in Canada.

Read More
Seneca Polytechnic logo

Seneca College Trade Show: Still Going Strong

The Seneca College Trade Show continues to connect opticianry students with key suppliers, associations and professionals across the optical industry.

Read More
The Vision Council logo

Vision Council Report: Eyecare Providers See Revenue Gains Despite Economic Pressures

The Vision Council’s Provider inSights report finds eyecare providers saw revenue gains and improved patient retention in late 2025 despite ongoing economic pressures.

Read More
Optik VOILA January-February 2026 Marchon LO2187_714

Modern Elegance in a Sleek Teardrop Silhouette

Longchamp’s LO2187 reinterprets the Roseau concept with a lightweight metal teardrop silhouette, bamboo-inspired bridge detailing, and refined comfort for everyday wear.

Learn More
CRO logo image for Research Updates in Optik magazine

Landmark Myopia Control Trial Receives Top Recognition

A landmark six-year clinical trial on dual-focus contact lenses confirms long-term effectiveness in slowing childhood myopia progression.

Read more
Next Gen OD Future Focus event Cross-border Guidance 2026

Future Focus Webinar Addresses Cross-Border Pathways for Canadian Optometry Students

The Future Focus Cross-Border webinar provided Canadian optometry students with guidance on immigration, licensing and returning to practice in Canada.

Read more
Seneca Polytechnic logo

Seneca College Trade Show: Still Going Strong

The Seneca College Trade Show continues to connect opticianry students with key suppliers, associations and professionals across the optical industry.

Read more
The Vision Council logo

Vision Council Report: Eyecare Providers See Revenue Gains Despite Economic Pressures

The Vision Council’s Provider inSights report finds eyecare providers saw revenue gains and improved patient retention in late 2025 despite ongoing economic pressures.

Read more
Optik VOILA January-February 2026 Marchon LO2187_714

Modern Elegance in a Sleek Teardrop Silhouette

Longchamp’s LO2187 reinterprets the Roseau concept with a lightweight metal teardrop silhouette, bamboo-inspired bridge detailing, and refined comfort for everyday wear.

Learn More
CRO logo image for Research Updates in Optik magazine

Landmark Myopia Control Trial Receives Top Recognition

A landmark six-year clinical trial on dual-focus contact lenses confirms long-term effectiveness in slowing childhood myopia progression.

Read more
Next Gen OD Future Focus event Cross-border Guidance 2026

Future Focus Webinar Addresses Cross-Border Pathways for Canadian Optometry Students

The Future Focus Cross-Border webinar provided Canadian optometry students with guidance on immigration, licensing and returning to practice in Canada.

Read more
Seneca Polytechnic logo

Seneca College Trade Show: Still Going Strong

The Seneca College Trade Show continues to connect opticianry students with key suppliers, associations and professionals across the optical industry.

Read more
The Vision Council logo

Vision Council Report: Eyecare Providers See Revenue Gains Despite Economic Pressures

The Vision Council’s Provider inSights report finds eyecare providers saw revenue gains and improved patient retention in late 2025 despite ongoing economic pressures.

Read more